CLEANTECH-FOR-EUROPE
8.7.2021 09:51:11 CEST | Business Wire | Press release
Cleantech for Europe , a new initiative created by Cleantech Group, supported by Breakthrough Energy, today presented its first ‘EU Quarterly Cleantech Briefing ’. The analysis finds that in the first half of this year more than €7 billion of venture capital was invested in cleantech innovation in the European Union (EU). With six months remaining in 2021, this figure has already beaten the previous annual record for Europe, set just last year at €4.7 billion.
In view of this momentum, Cleantech for Europe will bring together top cleantech leaders from VCs, startups, academia, and civil society to build much-needed bridges with policymakers in Brussels and other European capitals. In a first instance, six leading cleantech venture capital firms, regarded as pioneers in financing innovative low-carbon companies, are joining the initiative. Other communities from start-ups, scale-ups, academia and civil society will join the initiative over time to build a future-oriented, technology-savvy group of cleantech leaders from across the EU.
The six “Cleantech for Europe Leaders” are: Beamline Accelerator (Estonia), btov Industrial Tech Fund (Germany), Inven Capital (Czech Republic), Munich Venture Partners (Germany), Rockstart (Netherlands), and SET Ventures (Netherlands). Combined, these firms have invested in more than 150 innovative low-carbon start-ups and scale-ups, including global leaders such as Sonnen in batteries and Sunfire in hydrogen production. For the first time, these firms are coming together to build a collective voice and convey to policymakers and other stakeholders the importance of investing in the next generation of clean technologies.
Despite the fact that EU cleantech investments are booming compared to previous years, the EU Quarterly Cleantech Briefing notes they may still fall short of what is needed to ensure EU start-ups can scale up across the continent. In the past decade, EU companies seeking to scale have often turned toward Asia or North America for larger markets, more abundant funding and ambitious public policies that accelerate their adoption.
“This analysis illustrates the extraordinary progress of the EU’s cleantech ecosystem – and the mountain of urgent work that lies ahead, particularly around helping build an EU policy framework that prioritizes and supports cleantech innovation.” said Ann Mettler, Vice President Europe at Breakthrough Energy, an organization founded by Bill Gates to support the innovations that will lead the world to net-zero emissions.
The release of the investment tracker and the announcement of the Cleantech for Europe initiative come just days before the EU prepares to unveil its highly anticipated “Fit for 55” package of climate legislation, and as most EU member states are finalizing Covid economic recovery plans that the European Commission has stipulated must include strong climate- and clean energy-related components.
The analysis also found: increasing numbers of late-stage deals; major deals of €300 million or more in industries including batteries, electric mobility, shared mobility and the circular economy; and a sharp uptick in the number of deals in the materials and chemicals sector. Sign up for future quarterly briefings here .
The involvement of top venture capital firms in the Cleantech for Europe initiative underscores how important policy is to the success of cleantech innovation.
“The goal of the new initiative is to place cleantech innovation at the center of EU public policy debates in the coming weeks, months and years,” said Jules Besnainou, director at Cleantech Group, a research and consulting company that is helping organize the new group and author the quarterly briefings. “We want the bloc to capitalize on opportunities to build and expand clean industries, ensure a just transition, and mount a stronger response to a climate crisis which grows more urgent by the day.”
“The regulatory framework is critical for success in cleantech. We see it in hydrogen: strong policy moves result in market uptake.” added Ivo Němejc, Vice Chairman of the Board of Directors, Inven Capital
“It is still very hard for EU cleantech start-ups to scale beyond their national borders. If we want to lead the race to net zero, we need to start building continental champions.” said Martin Kröner, Managing Partner, Munich Venture Partners
“The energy transition is a systemic challenge, but also an opportunity for the EU to lead the world on climate innovation while creating high-quality jobs.” added René Savelsberg, Managing Partner and Co-Founder, SET Ventures
“To reach climate leadership, we must improve the funding cycle for EU cleantech. The time to act is now.” said Christian Reitberger, Partner, btov Industrial Tech Fund
“Our success in Estonia proves that efficient cooperation between policy-makers and cleantech leaders is in fact a must for sustainable innovation development.” added Erki Ani, CEO, Beamline Accelerator
Additional venture capital firms are expected to join the group in the coming months.
Specifically, the Cleantech for Europe initiative calls on the EU to:
- Create a demand shock for green solutions. Create sectoral transition plans. Implement a predictable and progressive price on carbon. Accelerate green public procurement.
- Support the creation of at least 10 EU scale-up funds. Increase non-dilutive funding. Leverage public-private instruments such as carbon contracts for difference.
- Support cross-border scaling. Harmonize regulations and standards to allow innovative companies scale from one country to the continent. Develop integrated value chains across all member states.
In unveiling the investment tracker, Cleantech for Europe also announced that it will hold an inaugural Cleantech for Europe Summit on September 8, featuring key leaders from Europe’s venture capital and policy communities. The Summit will be opened by Pascal Canfin, MEP and Chair of the Committee on the Environment, Public Health and Food Safety at the European Parliament. To participate in the Summit, sign up here .
To set up interviews with European venture capitalists and innovators active in the cleantech space, and policy experts, or to get more of the backstory on how and why the Cleantech for Europe initiative was conceived, please contact Jules Besnainou at hello@cleantechforeurope.com
About Cleantech for Europe
Cleantech for Europe is an initiative created by Cleantech Group, supported by Breakthrough Energy and leading EU cleantech investors. Our mission is to help the EU lead the race to net zero while creating long-term industrial competitiveness. We aim to put innovation at the center of the public policy debate and build bridges between the EU’s cleantech community and policymakers in Brussels and member states.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005349/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
